Novel Treatment Strategies and Latest Evidence for Metastatic Castration-Sensitive Prostate Cancer

Novel Treatment Strategies and Latest Evidence for Metastatic Castration-Sensitive Prostate Cancer
Chair, Matthew R. Smith, MD, PhD, Karim Fizazi, MD, PhD, and Sandy Srinivas, MD, discuss castration-sensitive prostate cancer in this CME/MOC activity titled “Realizing the Potential of Novel Treatment Intensification Strategies for Metastatic Castration-Sensitive Prostate Cancer: The Experts’ Take on Key Clinical Evidence, Practical Considerations, and Best Practices for Individualized, Patient-Centered Care.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/UDM865. CME/MOC credit will be available until July 5, 2023.